17814-85-6O=C(O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]MLOSJPZSZWUDSK-UHFFFAOYSA-N17814-85-6Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 1.9% (1 of 53) of reports.
Warning
H302 (13.2%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 53 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 20-07-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/16755
4-Carboxylbutyltriphenylphosphonium bromide: Does not have an individual approval but may be used under an appropriate group standard
Usessuzuki reaction
Uses(4-Carboxybutyl)triphenylphosphonium Bromide (cas# 17814-85-6) is a compound useful in organic synthesis.
UsesUsed as a platform for delivery of pro-apoptotic peptides into the mitochondria of tumor cellsReactant for preparation of:Ring skeletons via ring closing metathesis and double bond migration ring closing metathesis reactionsMethyl alkenyl quinolones as antimycobacterial agentsProstaglandins and their drug analogs via Gold-catalyzed Meyer-Schuster rearrangementDiphenylmethylpiperazines as N-type calcium channel blockers as potential therapeutic agentsFolate receptor-specific glycinamide ribonucleotide formyltransferase (GARFTase) inhibitors with antitumor activityCycloalkylidene alkanols with antileishmanial activity, via Wittig reaction
Loading…
DTXSID6057669CHEMBL3250674